For years, machine learning in drug discovery has been asked to choose: screen a library, assign a score and rank what already exists.
SYDRA has now built something fundamentally different.
Our new pipeline turns discriminative intelligence into a generative discovery process. It locates molecular signals worth pursuing, transforms them into starting points for new chemistry, generates unseen structures, judges them independently and moves selected designs through scientist-guided refinement.
The breakthrough is not any single model.
It is the architecture connecting the entire journey—from recognition to creation.
Existing molecules are no longer the boundary of the search. They are the foundation from which entirely new chemical space can emerge.
From discriminative AI to generative discovery.
Not a better filter. A new way to discover.
Generation proposes. Science judges. Biology decides.